MANY VASOACTIVE PEPTIDES ARE responsible for blood pressure regulation via dilation and constriction of blood vessels. Depending on the site of action, these peptides can cause diverse reactions. One of these peptides is the nonapeptide bradykinin (BK), which is formed when its precursor, the high molecular weight kininogen, is cleaved by the protease kallikrein (24) . BK exerts a variety of biological effects on the endothelium and peripheral circulation, inducing vasodilation and increasing blood flow by reducing the tonus of arterial smooth muscle (8) . At high concentrations, BK induces the constriction of airway smooth muscle, generating an effect comparable to patients suffering from asthma (5) . During inflammation, it promotes the migration of cells from the blood to the tissues activating different cells of the immune system (4) . These different cellular effects result from the activation of two receptors, bradykinin receptor type 1 (B 1 R), which is inducible, and the constitutively expressed bradykinin receptor type 2 (B 2 R) (12) . B 2 R binds BK and Lys-BK (kallidin) while B 1 R is activated by [Des-Arg 9 ]-BK and [Des-Arg 10 ]-kallidin (22) . Both receptors couple to the G-protein G q/11 , which leads via phospholipase C (PLC) activation to Ca 2ϩ mobilization (3, 35) . Activation of B 2 R on endothelial cells causes vasodilation and increased vascular permeability via increased cellular concentrations of Ca 2ϩ and the production of nitric oxide (13) . Due to those vascular effects on the blood vessels, BK is involved in numerous serious conditions such as formation of angioedema (2, 20) , induction of acute stroke (29) , and migration of prostate cancer cells (1) .
Another group of vasoactive peptides are natriuretic peptides (NP) that regulate blood pressure volume homeostasis, salt excretion, and diuresis (14) . Members of the human NP family are the atrial natriuretic peptide (ANP), the brain natriuretic peptide (BNP), the C-type natriuretic peptide (CNP), and urodilatin (URO; kidney isoform of ANP). All NP are synthesized as prepro-hormones that are cleaved upon secretion to smaller mature forms that have a ring-shaped peptide structure, formed by a disulfide bridge between two cysteine residues. They exert their biological functions mainly through activation of guanylate cyclase (GC) receptors and subsequently through an increase in intracellular cGMP (14) . GC-A [also known as natriuretic peptide receptor type A (NPR-A)] selectively binds ANP, BNP, and URO while the GC-B [natriuretic peptide receptor type B (NPR-B)] has a high affinity towards CNP. A splice variant of this receptor, NPR-Bi, is a truncated form that is widely expressed in human tissues and also binds CNP but lacks GC function and acts as a tyrosine kinase (15, 17) . A fourth type of receptor, the natriuretic peptide receptor type C (NPR-C) or clearance receptor, binds all NP but also lacks a GC domain (23) .
It is known that NP have beneficial effects on brain edema via still unknown mechanisms (25, 26) . One of the possible mechanisms is an interaction between NP and the BK signaling pathways. This study provides evidence that NP can influence the BK/B 2 R-dependent signaling pathway via cGMP and may indeed act as natural inhibitors of BK.
MATERIALS AND METHODS
Cell culture. Confluent HEK-293 cell monolayers were cultured on glass coverslips in DMEM with 3.7 g/l NaHCO 3 supplemented with 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin and 10% FCS in an atmosphere with 5% CO 2-95% air at 37°C. Cells were used for experiments 2-10 days after trypsinization (0.05% trypsin and 0.02% EDTA in Mg 2ϩ , Ca 2ϩ free phosphate buffer). Patch-clamp technique. Membrane voltages (Vm) of HEK-293 cells were measured using the slow whole cell patch-clamp technique (11) . Coverslips with HEK-293 cells were mounted at the bottom of a perfusion chamber on an inverted microscope (Axiovert 10; Zeiss, Göttingen, Germany). A modified Ringer solution containing 145 mmol/l NaCl, 1.6 mmol/l K 2HPO4, 0.4 mmol/l KH2PO4, 5 mmol/l D-glucose, 1.03 mmol/l MgCl2, and 1.3 mmol/l calcium gluconate (pH 7.4) was used as bathing solution. All substances used in the experiments were dissolved in the modified Ringer solution. Experiments were performed at 37°C with a bath perfusion rate of 10 ml/min. Patch-clamp pipettes were filled with a solution containing 95 mmol/l potassium gluconate, 30 mmol/l KCl, 4.8 mmol/l Na 2HPO4, 1.2 mmol/l NaH2PO4, 5 mmol/l D-glucose, 0.73 mmol/l calcium gluconate, 1 mmol/l EGTA, 1.03 mmol/l MgCl2, and 1 mmol/l ATP (pH 7.2). To permeabilize the membrane under the pipette allowing electrical access to the cell cytosol, 160 mol/l nystatin were added to the pipette solution (27) . The solution was sterile filtered before use. Patch-clamp pipettes had an input resistance of 8 -12 M⍀. V m was measured with a patch-clamp amplifier (U. Fröbe, Physiologisches Institut, Universität Freiburg, Germany) and recorded continuously with a pen chart recorder (WeKa graph WK-250R; WKK, Kaltbrunn, Switzerland).
RT-PCR analysis. Total RNA from harvested HEK-293 cells was isolated using the RNeasy Mini kit (Qiagen, Hilden, Germany). The cDNA first-strand synthesis was performed in a total reaction volume of 20 l containing 3 l mRNA, 1 l oligo (dT) 18 -primer (0.5 g/l), 8.5 l nuclease-free water, 4 l 5 ϫ reaction buffer, 0.5 l RiboLock RNase inhibitor (20 U/l), 2 l 10 mM dNTP mix, and 1 l RevertAid H Minus M-MulV reverse transcriptase (200 U/l), using the RevertAid H Minus first-strand cDNA synthesis kit (Fermentas, St. Leon-Rot, Germany). Then, 1 l of each cDNA first-strand reaction mixture was subjected to a 50-l PCR reaction in a Biometra TGradient 96 Thermocycler (Whatman Biometra, Göttingen, Germany) using 20 pmol of each primer and 1 unit of DreamTaq-DNA Polymerase (Fermentas). Reaction conditions were as follows: 3 min at 95°C, 30 s at 57-62°C and 30 s at 72°C, 1 cycle; 30 s at 57-62°C and 30 s at 72°C, 34 cycles for PCR reactions or 25 cycles for reamplification reactions; 30 s at 57-62°C and 10 min at 72°C, 1 cycle. PCR reaction products were analyzed by agarose gel electrophoresis. All positive signals obtained from PCR experiments were sequenced by GATC (Konstanz, Germany).
The following PCR primers for the receptors were used (listed in 5= to 3= direction). The numbers in brackets refer to the expected Results are means Ϯ SE; n ϭ number of experiments; ⌬ indicates membrane voltage differences between the effector and the respective pre-and postcontrols. Vm, membrane voltage; ANP, atrial natriuretic peptide, URO, urodilatin; BNP, brain natriuretic peptide; CNP, C-type natriuretic peptide; BK, bradykinin. Fig. 2 . Concentration-dependence curves for the natriuretic peptides urodilatin (URO; A), atrial natriuretic peptide (ANP; B), and brain natriuretic peptide (BNP; C). Membrane voltage differences (⌬Vm) were measured using the slow whole cell patch-clamp technique. URO shows its strongest depolarizing effect at concentrations of 10 -100 nM. ANP displays its strongest depolarizing effect at a concentration of 10 nM while BNP induces an equally strong depolarizing effect from 1-1,000 nM. Results are means Ϯ SE. Number of experiments is given in brackets. *P Ͻ 0.05, statistically significant effect compared with control. 6 cells were incubated in fluo 4-AM-loading medium for 30 min at room temperature protected from light. Thereafter, cells were washed twice in HHB medium followed by incubation in HHB medium for 15 min at room temperature and 15 min at 37°C for deesterification. Ca 2ϩ flux was measured for 204 s using a FACSCalibur (Becton Dickinson, Heidelberg, Germany). Equal volumes of stimuli and inhibitors dissolved in HHB medium were added 30 s after the beginning of each measurement. Background noise was defined using the equal volume of HBB medium without stimuli or inhibitors. Data analysis was performed using FlowJo 7.6.5 (Tree Star, Ashland, OR), and data are presented as mean fluorescence intensity of the median including background noise correction expressed in relative fluorescence units (rFU).
Biochemical reagents. DMEM, L-glutamine solution, penicillinstreptomycin, fetal calf serum, BSA, HBSS, HEPES, trypsin, BK, 8-bromo-(8-Br)-cGMP, HOE 140, 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB), KT 5823, UTP and U-73122 were purchased from Sigma-Aldrich Chemie (Taufkirchen, Germany), 2-aminoethoxydiphenyl borate (2-APB), [Des-Arg 9 ]-bradykinin, and CCG-63802 were obtained from R&D Systems (Wiesbaden-Nordenstadt, Germany). ANP, BNP, CNP, and URO were obtained from Pharis Biotec (Hannover, Germany). All other standard chemicals were supplied by Sigma-Aldrich Chemie and Merck (Darmstadt, Germany).
Statistical analyses. For statistical analyses, Student's paired and unpaired t-test was used where appropriate with each effect compared with its own control. When more than two parameters were tested, ANOVA with Tukey as post hoc test was applied. Data are presented as mean values Ϯ SE. The number of experiments is given in brackets. A P value Ͻ 0.05 was considered significant.
RESULTS

RT-PCR and general characteristics of HEK-293 cells.
To investigate the interactions between NP and BK, we used HEK-293 cells, which express mRNA for four different NP receptors (NPR-A; NPR-B; a splice variant of NPR-B, NPRBi; and clearance receptor NPR-C) as well as both BK receptors (B 1 R and B 2 R) as shown by RT-PCR (Fig. 1) .
HEK-293 cells were used from passages 2 to 197, 2-10 days after trypsinization (average 6 days). Basal membrane voltages (V m ) were monitored, and depolarizations caused by an increase of extracellular K ϩ concentration by 15 mM (⌬K ϩ ) were used before each experiment to test the viability of cells. The resting potential (V m ) was Ϫ54.1 Ϯ 1.0 mV (n ϭ 210) and under K ϩ 18.6 mM cells depolarized by ⌬V m ϭ 9.9 Ϯ 0.4 mV (n ϭ 210) as shown in Table 1 .
Effects of NP on membrane voltages (V m ) of HEK-293 cells.
To define the concentration of NP to be used in this study, concentration-dependence curves (10 Ϫ10 M to 10 Ϫ6 M) were determined for ANP, URO, and BNP (Fig. 2) BaCl 2 ruling out the involvement of K ϩ channels (Fig. 3A) . However, 10 M NPPB completely reversed the BK-induced depolarization (from ⌬V m ϭ 3.3 Ϯ 0.6 to Ϫ0.4 Ϯ 0.6 and back to 2.2 Ϯ 0.3 mV, n ϭ 6 and postcontrol n ϭ 5) indicating the activation of Ca 2ϩ -dependent Cl Ϫ channels by BK (Fig. 3B) . As already shown, mRNA of two types of BK receptors is expressed in HEK-293 cells (Fig. 1) . While BK, a selective agonist of the B 2 R, led to an increase in intracellular Ca 2ϩ (Fig. 4A) , [Des-Arg 9 ]-bradykinin, a selective activator of the B 1 R, did not (Fig. 4B) . Furthermore, HOE 140, a selective B 2 R antagonist, completely blocked depolarizations caused by BK (from ⌬V m ϭ 2.6 Ϯ 0.5 to Ϫ0.6 Ϯ 0.7 and back to 2.2 Ϯ 0.8 mV, n ϭ 5) at a concentration of 100 nM (Fig. 4C) .
Inhibition of BK effects by NP in HEK-293 cells.
To test whether NP interact with the signaling pathway of BK, we used ANP, its kidney isoform URO, BNP, and CNP. As shown in Fig. 5 , ANP (A), URO (B), and BNP (C; 10 nM each) inhibited BK-induced depolarizations (ANP from ⌬V m ϭ 4.3 Ϯ 0.9 to Ϫ3.7 Ϯ 0.4 and back to 1.7 Ϯ 0.3 mV, n ϭ 5; URO from ⌬V m ϭ 3.5 Ϯ 0.6 to Ϫ1.8 Ϯ 0.6 and back to 2.5 Ϯ 0.5 mV, n ϭ 6; and BNP from ⌬V m ϭ 2.0 Ϯ 0.3 to Ϫ1.5 Ϯ 0.6 and back to 1.8 Ϯ 0.2 mV, n ϭ 6; the postcontrols in all experiments were n ϭ 3). Furthermore, URO was also found to completely suppress the BK-induced intracellular Ca 2ϩ signal (Fig. 6) . The peak value under BK dropped significantly from 45.4 Ϯ 11.0 to 5.4 Ϯ 12.2 rFU when URO was present. CNP (10 nM), an activator of NPR-B (GC-B), was neither able to inhibit BK-induced depolarizations (from ⌬V m ϭ 3.9 Ϯ 0.8 to 3.1 Ϯ 0.8 and back to 2.1 Ϯ 0.5 mV, n ϭ 6, postcontrol n ϭ 4) nor could it block the BK-induced intracellular Ca 2ϩ signal (Fig. 7) . The peak value under BK did not drop significantly from 15.7 Ϯ 1.6 to 10.4 Ϯ 3.6 rFU when CNP was present, but CNP was still able to depolarize cells by ⌬V m ϭ 2.5 Ϯ 0.6 mV (n ϭ 6) via inhibition of K ϩ channels acting through NPR-Bi. Since ANP, URO, and BNP increase intracellular cGMP con- centrations via NPR-A (GC-A), the cGMP membrane permeable analog 8-Br-cGMP was tested and depolarized cells in a concentration of 100 M comparable to NP ( Table 1) . As expected, 8-Br-cGMP also inhibited BK-induced depolarizations (from ⌬V m ϭ 3.1 Ϯ 0.7 to Ϫ0.8 Ϯ 0.6 and back to 1.1 Ϯ 1.0 mV, n ϭ 6; postcontrol n ϭ 4, Fig. 8 ) as well as intracellular Ca 2ϩ signaling (33.3 Ϯ 6.2 to 8.9 Ϯ 4.8 rFU, n ϭ 4; Fig. 9 ; note: for Ca 2ϩ experiments, 8-Br-cGMP was used in a concentration of 500 M due to the standing bath conditions).
Cross talk between signaling pathways of NP and BK. After activation of GC-A by NP, increased levels of cGMP activate the cGMP-dependent protein kinase (PKG). The effects of URO on depolarizations caused by BK are completely abolished by 1 M KT 5823, an inhibitor of PKG (Fig. 10) , demonstrating the involvement of PKG in the cross talk between the signaling pathways of NP and BK (BK and URO: ⌬V m ϭ Ϫ0.5 Ϯ 0.4 mV; BK and URO plus KT 5823: ⌬V m ϭ 2.5 Ϯ 0.6 mV; BK and URO postcontrol: ⌬V m ϭ 1.9 Ϯ 0.5 mV, n ϭ 4). Here, the postcontrol displays no significant difference to the effect due to the longer retention period of the membrane permeable KT 5823 in the cell.
The BK signaling pathway via B 2 R involves the activation of PLC and an increase in intracellular Ca 2ϩ from the endoplasmic reticulum that could be completely inhibited by the inositol 1,4,5-trisphosphate receptor blocker 2-APB (50 M; from 35.9 Ϯ 8.2 to Ϫ2.1 Ϯ 2.6 rFU, n ϭ 4). To analyze the various steps in the upstream BK signaling pathway, the PLC inhibitor U-73122 (10 M) was used. 10 M U-73122 completely blocked the BK-induced depolarization from ⌬V m ϭ 2.2 Ϯ 0.3 to Ϫ1.8 Ϯ 0.4 and back to 0.8 Ϯ 0.8 (n ϭ 6, postcontrol n ϭ 3; Fig. 11 ). To test whether NP are actually Fig. 10 . Reverse effect of the cGMP-dependent protein kinase (PKG) inhibitor KT 5823 on the BK-induced depolarization blocked by URO in HEK-293 cells. Inhibitory effect of 10 nM URO on depolarizations caused by BK is completely abolished by 1 M KT 5823 (black bar), a membrane permeable PKG inhibitor. Membrane voltage differences (⌬Vm) were measured using the slow whole cell patch-clamp technique. Results are means Ϯ SE. Number of experiments is given in parentheses. *P Ͻ 0.05, statistically significant effects compared with precontrol (dark gray bar). Postcontrol (light gray bar) displays no significant difference to the effect due to the longer retention period of the membrane permeable KT 5823 in the cell. interacting with the PLC pathway via cGMP, a second activator of PLC was used. UTP, an agonist of the P2Y receptor, increased intracellular Ca 2ϩ (Fig. 12A) , which could not be blocked by 8-Br-cGMP (Fig. 12B ) but by the PLC inhibitor U-73122 (from 51.6 Ϯ 13.5 to Ϫ6.5 Ϯ 5.5 rFU, n ϭ 4; Fig.  12C ). Since B 2 R is a G-protein coupled-receptor that is regulated by regulators of G-protein signaling (RGS) proteins, the influence of the RGS protein blocker CCG-63802 (5 M) was tested (Fig. 13) . BK in the presence of 8-Br-cGMP did not display significant depolarizations (precontrol: ⌬V m ϭ Ϫ1.5 Ϯ 0.9 mV, n ϭ 4; postcontrol: ⌬V m ϭ Ϫ1.0 Ϯ 1.5 mV, n ϭ 3) while in the presence of CCG-63802, inhibiting RGS proteins, cells depolarized to ⌬V m ϭ 2.0 Ϯ 0.7 mV (n ϭ 4), indicating that PKG acts via RGS proteins to regulate the BK receptor and its Ca 2ϩ signaling (Fig. 14) . CCG-63802 on its own had no effect on membrane voltage (⌬V m ϭ Ϫ1.5 Ϯ 0.5 mV, n ϭ 4).
DISCUSSION
BK is known to be involved in various pathological conditions such as angioedema (2, 20) , acute stroke (29) , and migration of prostate cancer cells (1) . At high concentrations, it can cause increased vasoconstriction inducing asthma-like conditions in the lung (5) . The activation of its type 2 receptor (B 2 R) induces vasodilation and increased vascular permeability and is thought to be responsible for causing these different types of injuries and tissue damages (12, 22) . Therefore, the search for inhibitors of the BK signaling cascade including the blockage of B 2 R as therapeutic tools has become an important issue (2, 7, 24, 29, 31, 32) . In HEK-293 cells, both BK receptors are expressed (21) . The type 1 receptor needs to be induced and transferred to the membrane (5) . In this experimental series it could not be activated by its specific agonist [Des-Arg 9 ]-bradykinin while the type 2 receptor is constitutively expressed (5) and exerted a Ca 2ϩ response when bound by BK.
NP are known to have beneficial effects in different cases of interstitial edema in a still unknown manner (25, 26) . To investigate a possible interaction of signaling pathways between BK and NP, we used HEK-293 cells since these cells also express mRNA of several NP receptors besides the two known BK receptors (16) . The inhibition of K ϩ channels via ANP through NPR-A, cGMP, and PKG has previously been shown (16) and could be verified in this study. Unlike before, we were able to verify the presence of mRNA of the NPR-B via RT-PCR but only after reamplification. Nevertheless, CNP does not act via NPR-B but NPR-Bi, a splice variant of NPR-B, which shows a much higher distribution in distal tubules compared with NPR-B (17). This also explains why CNP did not block the BK-induced Ca 2ϩ signal but still depolarized HEK-293 cells by inhibiting K ϩ channels, since those channels cannot only be inhibited by PKG phosphorylation via NPR-A and cGMP but also by tyrosine phosphorylation as it has been described for the NPR-Bi (16, 17 -dependent Cl Ϫ channels. Such an activation of chloride currents by BK has been demonstrated before in epithelial kidney cells (Madin-Darby canine kidney) and non-neuronal cells (10, 28) . Since NP and BK activate or inhibit different kinds of ion channels both resulting in depolarizations, the interaction of the signal pathways is not located at the ion channel site but somewhere upstream in the signaling cascades. The effect of NP on BK was absent in the presence of the PKG inhibitor KT 5823, showing the involvement of this protein kinase in the cross talk between NP and BK. For PKG, there are several possible targets in the BK signaling cascade, e.g., it has been shown that PKG can inhibit PLC via direct phosphorylation (34) as well as interact with the inositol 1,4,5-trisphosphate receptor (30) , blocking the Ca 2ϩ release from the endoplasmic reticulum. Our experiments show that the actual target is in between B 2 R and PLC since the Ca 2ϩ response of another activator of PLC, namely UTP, could not be inhibited by 8-Br-cGMP. B 2 R is a G-protein-coupled receptor and, furthermore, regulated by RGS proteins (18) . It has previously been demonstrated that PKG can activate RGS proteins (RGS4) to inhibit the G-protein-coupled receptor and thus either activate RGS4 in aortic smooth muscle cells (19) or mediate antihypertrophic effects of NP in the heart (33) . CCG-63802 is a specific inhibitor of RGS proteins with highest specificity for RGS4 (6) . Here, we show that inhibition of BK via 8-Br-cGMP was successfully reversed by the RGS protein inhibitor CCG-63802. This indicates the direct interaction of the cGMP pathway with the BK signaling pathway through the regulation of RGS proteins, comparable to the mechanism described before in cardiac myocytes (33) . Figure 14 displays a schematic overview of the signaling pathways of BK and NP in HEK-293 cells.
In conclusion, as natural antagonists of the B 2 R signaling pathway, NP may positively interact in pathological conditions caused by BK, while further experiments are needed to verify the roles of BK and NP in their regulatory interaction.
